echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Blood sugar control can reverse diabetes-related brain damage

    Blood sugar control can reverse diabetes-related brain damage

    • Last Update: 2022-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

           


    The new study shows that the brain damage that type 1 diabetes causes to adolescents is reversible
    .


    Researchers from Stanford University School of Medicine and the Nemoor Children's Health Center in Jacksonville collaborated to lead the proof-of-concept pilot study, the most thorough investigation
    on the topic to date.


                    

    "These results offer hope for the damage that type 1 diabetes can do to the developing brain, which may be reversible with strict glucose control," said Nelly Mauras, MD, a pediatric endocrinologist at the Nemol Children's Health Center in Jacksonville and a professor of pediatrics at
    the Mayo Clinical School of Medicine, senior author and co-lead investigator of the paper.


    The study was conducted
    through the Five Centers Pediatric Diabetes Research Network (DirecNet).


    Dr.


    Mixing a closed-loop insulin delivery system, when used properly and continuously, can increase blood sugar in a healthy range of time
    .


    Participants who used closed-loop glucose control systems showed significantly greater improvements in key brain indicators that reflected normal teen brain development than the standard care group — in other words, their results were closer to those of adolescents
    without diabetes.


    "We have long known that better control of blood sugar levels in people with type 1 diabetes can prevent or reduce damage to some biological systems (e.


    Type 1 diabetes is an autoimmune disease in which a patient's immune system mistakenly destroys insulin-producing cells
    in the pancreas.


    A Pilot randomized trial to examine effects of a hybrid closed-loop insulin delivery system on neurodevelopmental and cognitive outcomes in adolescents with type 1 diabetes    

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.